FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Antenatal Screening Market Overview:

Antenatal screening, also known as prenatal screening, refers to medical tests and assessments performed during pregnancy to assess the health of the fetus and the mother. The primary goal of antenatal screening is to identify potential risks, health conditions, or abnormalities that could affect the pregnancy, the fetus, or the mother's health. Selection is needed since, for most disorders, diagnosis is only possible by an invasive procedure, which carries a slight risk of miscarriage. The main methods are amniocentesis and chorionic villus sampling (CVS). Screening does not replace diagnosis; it aims to provide information that can help decision-making.

Antenatal screening is widely used in modern obstetrics and gynecology, offering a comprehensive approach to prenatal care. By employing a range of advanced medical tests and technologies, healthcare professionals can effectively assess the health of both the mother and the developing fetus. This proactive strategy allows for the timely detection of potential risks, genetic abnormalities, and maternal health issues, enabling personalized and informed decision-making to optimize pregnancy outcomes and ensure the well-being of both mother and baby. As medical technology continues to evolve, antenatal screening methods are likely to become even more accurate and comprehensive, leading to further improvements in the care of pregnant individuals and their unborn children.

FutureWise Market Research has published a report that provides an insightful analysis antenatal screening market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antenatal screening market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

Major players included in the Antenatal Screening Market:

GymnaUniphy
Biotec Italia srl.
Cyronics Instruments Pvt. Ltd.
Oakworks Med
India Viking ImpEx Private Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Antenatal Screening Market :

In August 2022- F. Hoffman-La Roche AG launched the Digital LightCycler System, a next-generation digital PCR system that helps doctors better understand the nature of genetic diseases.
August 2022: Natera Inc. filed a pre-submission to FDA (the Food and Drug Administration) for its panorama non-invasive prenatal test (NIPT) as part of the Q-Sub process. The company filed its pre-submission in June 2022 for fetal chromosomal aneuploidies and 22q11.2 deletion syndrome.

The growing prevalence of genetic disorders and congenital malformations is anticipated to significantly drive the growth of the antenatal screening market during the forecast period. As individuals become aware of the potential risks and seek early detection, healthcare professionals are increasingly adopting advanced screening technologies to provide accurate examinations and informed decision-making options, facilitating a vigorous demand for the antenatal screening market. This trend is particularly evident as more countries prioritize comprehensive prenatal care and incorporate advanced screening techniques into routine medical practices. For instance, approximately 90% of women in the UK have undergone either one of these procedures at some point during their pregnancy. Although there is only a slight difference between the two procedures, health authorities categorize them separately as antenatal screening and antenatal diagnosis. Furthermore, the possibility of false positive or false negative results in screening tests presents a prominent constraint within the antenatal screening market. While these tests are vital for identifying risks and making informed decisions, the inherent risk of incorrect results may cause unnecessary stress for expecting parents and healthcare providers. False positives may lead to extreme anxiety and interventions, while false negatives could result in missed diagnoses and delayed necessary medical attention. This challenge emphasizes the need for continuous improvement in the accuracy and reliability of screening methodologies to ensure the well-being of both mothers and infants. Moreover, the significant cost implications of advanced antenatal screening techniques pose a substantial restraint, potentially restricting access, particularly within low-income and developing regions. The expense encompasses screening procedures, the required infrastructure, specialized equipment, and skilled staff. This financial burden may hinder equitable access to these crucial services, worsening healthcare differences and impeding early detection and intervention efforts for genetic disorders and congenital abnormalities among vulnerable populations. Furthermore, with the increasing availability of direct-to-consumer (DTC) tests, these assessments are conveniently accessible for purchase in physical retail outlets and online platforms, further driving the market's growth. While DTC tests present an opportunity for genetic analysis, they need a medical foundation and disregard the specialized and personalized interpretation of results typically offered by healthcare experts. For instance, in the United States, DTC genetic testing services have the potential to serve as a mechanism to tackle the challenge of restricted access to genetic service providers.

Antenatal Screening Market Segmentation:

By Product Type

Amniocentesis
Specialist ultrasound
Ultrasound
Chorionic villus sampling

By Indication

Anencephaly
Exomphalos
Gastroschisis
Spina Bifida
Exomphalos
Others

By End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Diagnostic Centers

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to the high maternal mortality rate, high preterm birth rate, and rising incidences of chromosomal abnormalities will likely increase the demand for tests in this region. In addition, the rise in the number of pregnant women undergoing genetic screening in this region also contributes to the market's growth. Various research studies provide insight into the efficacy of awareness about prenatal care. For instance, in August 2022, research published in the National Library of Medicine stated that advancements in antenatal care have increased awareness of malpresentation and fetal malformations and are expected to improve preparation for high-risk deliveries. Hence pregnant women should closely follow prenatal care guidelines to achieve the best possible results for both pregnancy and childbirth. The mentioned factors will continue fueling market growth during the forecast period.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Antenatal Screening Market By Procedure Type, By Indication, By End User and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Global Antenatal Screening Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Antenatal Screening Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Antenatal Screening Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Antenatal Screening Market, By Procedure Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Amniocentesis
  2. Specialist ultrasound
  3. Ultrasound
  4. Chorionic villus sampling
8. Global Antenatal Screening Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Anencephaly
  2. Exomphalos
  3. Gastroschisis
  4. Spina Bifida
  5. Exomphalos
  6. Others
9. Global Antenatal Screening Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Hospitals
  2. Specialty Clinics
  3. Ambulatory Surgical Centers
  4. Diagnostic Centers
10. North America Antenatal Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
11. Latin America Antenatal Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
12. Europe Antenatal Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
13. Asia Pacific Antenatal Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
14. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Saudi Arabia
  2.2. UAE
  2.3. South Africa
  2.4. Egypt
  3. Market Size (USD Million) Forecast for MEA 2023-2031
15. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. GymnaUniphy
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Biotec Italia srl.
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Cyronics Instruments Pvt. Ltd.
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Oakworks Med
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. India Viking ImpEx Private Ltd.
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
17. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients